New Treatments For Parkinson'S Disease 2024. A small new trial published in the journal nature medicine describes what would be two firsts for parkinson's disease, if they pan out: Right now, the main treatment available to patients is.
Right now, the main treatment available to patients is. Prasinezumab, an experimental monoclonal antibody treatment, may help reduce the deterioration of motor skills in people with rapidly progressing parkinson’s.